Episode Details

Back to Episodes

London Drugs' New Leader: A Tech-Forward Shift

Published 1 day, 2 hours ago
Description

Clint Mahlman, London Drugs president and COO, retires after 41 years, leaving a tech-focused Nick Curalli to lead. Mahlmans journey from stock boy to executive showcases servant leadership and commitment to customer loyalty. Curallis internal rise mirrors the Louie familys legacy, ensuring a smooth transition.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/d3f91dc083ae64f0

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us